Literature DB >> 21952097

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

Afsaneh Shirani1, Yinshan Zhao, Elaine Kingwell, Peter Rieckmann, Helen Tremlett.   

Abstract

BACKGROUND: Recent natural history studies suggest that multiple sclerosis (MS) is a more slowly progressing disease than previously thought. These observations are from studies separated by time, geography and methodological approach.
OBJECTIVES: We investigated whether MS disease progression has changed over time in British Columbia, Canada.
METHODS: The British Columbia MS database was queried for relapsing-onset MS patients with symptom onset from 1975 to <1995, first assessed within 15 years from onset and with at least two Expanded Disability Status Scale (EDSS) scores. Latest follow-up was to 2009. Patients were grouped by 5-year onset intervals (1975 to <1980, 1980 to <1985, 1985 to <1990, 1990 to <1995). Outcome was defined as time to reach sustained and confirmed EDSS 6 within 15 years of disease duration. Kaplan-Meier analysis was used to compare: the proportion of patients reaching EDSS 6 (primary analysis) and the time to EDSS 6 (secondary analysis) across the time-period groups.
RESULTS: A total of 2236 relapsing-onset MS patients (73.4% female; mean age at onset: 32.3 ± 8.8 years) were included. No significant temporal trend was found in the proportion of patients reaching EDSS 6 within 15 years from onset (28.5%, 26.4%, 27.7%, 22.3% for intervals 1975 to <1980, 1980 to <1985, 1985 to <1990, 1990 to <1995, respectively; p = 0.09) or in survival curves for time to reach the outcome (p = 0.14).
CONCLUSIONS: Rates of disease progression remained relatively stable over two decades of MS onset in British Columbia, Canada. Our results suggest that differences in disease progression findings between natural history studies may be related to factors other than time period.

Entities:  

Mesh:

Year:  2011        PMID: 21952097     DOI: 10.1177/1352458511422097

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  22 in total

1.  Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.

Authors:  Omid Beiki; Paolo Frumento; Matteo Bottai; Ali Manouchehrinia; Jan Hillert
Journal:  JAMA Neurol       Date:  2019-06-01       Impact factor: 18.302

Review 2.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Amr H Sawalha; Yuichiro Itoh
Journal:  Mult Scler       Date:  2018-01       Impact factor: 6.312

4.  Obstetrical epidural and spinal anesthesia in multiple sclerosis.

Authors:  Ellen Lu; Yinshan Zhao; Leanne Dahlgren; Roanne Preston; Mia van der Kop; Anne Synnes; A Dessa Sadovnick; Anthony Traboulsee; Helen Tremlett
Journal:  J Neurol       Date:  2013-07-18       Impact factor: 4.849

Review 5.  Sex differences in autoimmune disorders of the central nervous system.

Authors:  Stefan M Gold; Anne Willing; Frank Leypoldt; Friedemann Paul; Manuel A Friese
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 6.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

7.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.

Authors:  Blake C Jones; Govind Nair; Colin D Shea; Ciprian M Crainiceanu; Irene C M Cortese; Daniel S Reich
Journal:  Neuroimage Clin       Date:  2013-08-13       Impact factor: 4.881

8.  Hospitalization rates and discharge status in multiple sclerosis.

Authors:  Sanober Nusrat; David Levinthal; Klaus Bielefeldt
Journal:  Mult Scler Int       Date:  2013-05-13

9.  Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Authors:  H Tedeholm; J Lycke; B Skoog; V Lisovskaja; J Hillert; C Dahle; J Fagius; S Fredrikson; A-M Landtblom; C Malmeström; C Martin; F Piehl; B Runmarker; L Stawiarz; M Vrethem; O Nerman; O Andersen
Journal:  Mult Scler       Date:  2012-11-01       Impact factor: 6.312

10.  Anorectal dysfunction in multiple sclerosis: a systematic review.

Authors:  Sanober Nusrat; Elsie Gulick; David Levinthal; Klaus Bielefeldt
Journal:  ISRN Neurol       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.